Delta Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Delta Financial Group’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$336K	Hold	509	–	–	0.08%	184
2024 Q4	$363K	Hold	509	–	–	0.09%	167
2024 Q3	$535K	Sell	509 -50	-9%	-$55.6K	0.2%	67
2024 Q2	$588K	Hold	559	–	–	0.25%	55
2024 Q1	$538K	Sell	559 -100	-15%	-$95.1K	0.16%	109
2023 Q4	$579K	Hold	659	–	–	0.18%	100
2023 Q3	$542K	Hold	659	–	–	0.19%	95
2023 Q2	$474K	Sell	659 -201	-23%	-$155K	0.56%	45
2023 Q1	$707K	Buy	860 +1	+0.1%	+$754	0.28%	64
2022 Q4	$611K	Buy	+859	New	+$634K	0.27%	71

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Delta Financial Group's REGN Position: Q1 2025 in Review

Delta Financial Group held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2025 at 509 shares worth $336K. The position accounts for 0.08% of the portfolio, ranked #184.

Delta Financial Group first reported a position in REGN in Q4 2022 and has held it in 10 quarters since. The position peaked at $707K in Q1 2023. 1,290 funds tracked by Wall St. Rank hold REGN as of Q1 2025.

Delta Financial Group held 509 shares of Regeneron Pharmaceuticals worth $336K as of Q1 2025.
Delta Financial Group left its Regeneron Pharmaceuticals share count unchanged in Q1 2025.
Regeneron Pharmaceuticals made up 0.08% of Delta Financial Group's portfolio in Q1 2025, its #184 holding.
Delta Financial Group first reported a position in Regeneron Pharmaceuticals in Q4 2022 and has held it in 10 quarters since.
Delta Financial Group's Regeneron Pharmaceuticals position peaked at $707K in Q1 2023.
1,290 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2025.

Based on Delta Financial Group's 13F filing for Q1 2025, filed 9 May 2025.